diabetestalk.net

Type 1 Diabetes And Intimacy: Reducing Burden In The Bedroom

Type 1 Diabetes and Intimacy: Reducing Burden in the Bedroom

Type 1 Diabetes and Intimacy: Reducing Burden in the Bedroom

Here on Glu, we offer people living with type 1 diabetes the chance to be open and honest, sharing challenges and gaining support from others who know how much this disease can get in the way of life. Having an anonymous forum allows us to gain real perspective on some deeply personal matters.
Several months ago, we polled the community on one of our most personal topics to date: physical intimacy.
In response, 63% of the community reported that T1D has had a negative effect in this area of their lives, blaming devices, sudden swings in blood sugar, and recurrent infections. Likewise, there is at least one published research study proving that people with diabetes and poor glycemic control reported significantly reduced intimacy and satisfaction in their marriages(1).
In a follow-up question, we learned how people’s sex lives have been affected. Here is a list of the most commonly reported problems, and potential strategies for solving them.
“My blood glucose is too low for sex.”
Having low blood sugar (BG) can interrupt anything; you just have to put everything else on hold and deal with it immediately. As the most commonly mentioned barrier to sex (one user commented that low blood sugar can “really kill the moment”), knowing your BG prior to sex is always a smart idea, as is adjusting any dose of rapid insulin prior to activity. Additionally, having a small snack before any physical activity may help prevent a low. You can also keep some ‘fast carbs’ near the bed, such as juice, gummy snacks, or glucose tabs. If you do experience a low during sex, despite y Continue reading

Rate this article
Total 1 ratings
Okra & Diabetes: Does it Help with Blood Glucose?

Okra & Diabetes: Does it Help with Blood Glucose?


Okra & Diabetes: Does it Help with Blood Glucose?
Okra & Diabetes: Does it Help with Blood Glucose?
Diabetes is a complicated disease and a diabetic patient has to absorb a host of precautions while including something new in the daily diet. Okra has been in news for quite some time and it has been claimed to have anti-diabetic properties. Let us explore the relationship between okra and diabetes in this article. Join in for the article Diabetes and Okra: Does it Help in Blood Glucose?
Very few people are aware of the term okra. Hence, before trying to understand the relation between okra and diabetes, let us know a few facts about the vegetable.
It is also known as ladys fingers in most part of the world.
It is a rich source of various minerals and vitamins such as potassium, calcium, folic acid, as well as Vitamin C.
The vegetable is low in calories and has a high content of fibre in it.
Most of the times, diabetes patients ask the question whether consumption of okra does any help to maintaining blood glucose.
Okra water does help in improving the blood sugar levels. This is particularly true for gestational diabetes .
Roasted okra seeds are also helpful in stabilizing blood sugar.
Okra helps treat blood glucose by reducing the rate in which sugar is used up from the intestines of our body.
Okra also contains insoluble fiber which is very important in stabilizing blood glucose.
Health Benefits of Okra for Diabetes Patients
The reason for all the hype about okra being beneficial for the diabetic patients is as follows:
The vegetable is a rich source of fib Continue reading

10 Questions to Ask an Endocrinologist (Diabetes Specialist) As a Patient

10 Questions to Ask an Endocrinologist (Diabetes Specialist) As a Patient


List of Questions to Ask an Endocrinologist (Diabetes Specialist) As a Patient
List of Questions to Ask an Endocrinologist (Diabetes Specialist) As a Patient
A thing about being medical patient is that youre quite impatient about your health. No thats not a paradox, a patient seeking services of a medical advisor is always impatient about whats going on with their body and thereby want to know more about it. Maybe its a reason why confront the doctor with a list of questions, dont we?
But hey thats a good thing to do. Asking the doctor, a host of interrogative questions will help the doctor and yourself know better about your health and proper diagnosis shall follow upon. In fact, its strongly advised to speak off clearly with your doctor when it comes health issues.
However, there have been times when weve been reluctant to ask questions to our doctor. And at other times, doctors have been reluctant to discuss the whole terminology at once. This might necessarily not be a good practice to preach upon. And when the case renders diabetes, theres every need that you ask your doctor things relating to your case.
So here we are, with a list of questions to allow you impetus on your diabetic symptoms and case. This will help you out on your next visit to the doctor or the endocrinologist as we know by.
Read along and get to know the List of Questions to Ask an Endocrinologist (Diabetes Specialist) as a patient.
1. How often should I check my blood sugar levels?
The first and foremost thing to ask your endocrinologist is how often you should be checking your blood sugar Continue reading

Highlights from American Diabetes Association 2017

Highlights from American Diabetes Association 2017


This years American Diabetes Association (ADA) meeting took place in San Diego, California from June 9th to June 13th. The event provides the setting for physicians, industry, and academia to come together to discuss all topics type 2 diabetes (T2D)-related. Among the announcements that were of particular interest were trial results for several current and emerging therapies.
Benefits of Novo Nordisk s Xultophy compared with basal-bolus insulin: Xultophy, a fixed dose combination (FDC) of the long-acting insulin Tresiba and the glucagon-like peptide-1 ( GLP-1 ) receptor agonist Victoza , demonstrated similar HbA1c reductions as a basal-bolus insulin regimen (insulin glargine U100 and insulin aspart), but also provided significantly lower rates of hypoglycemia and a decrease in weight. Approximately two-thirds of patients on Xultophy, reached an HbA1c target of < 7% while there was an 89% reduction in severe hypoglycemic events compared with basal-bolus insulin therapy. Furthermore, the Xultophy group required a lower daily dose of insulin versus the basal-bolus treatment arm. Xultophy is competing against Sanofis long-acting insulin/GLP-1 receptor agonist FDC Soliqua , a fusion of Lantus with Adlyxin. The widespread use of Lantus over Tresiba in the United States should result in strong physician willingness to prescribe Soliqua. However, Victozas dominance in the GLP-1 receptor agonist market, combined with its cardiovascular (CV) benefit, and the new efficacy data showcased during the ADA meeting, indicates that Soliqua will struggle to overtake Xultophy as the market Continue reading

Understanding 30-day re-admission after hospitalisation of older patients for diabetes: identifying those at greatest risk

Understanding 30-day re-admission after hospitalisation of older patients for diabetes: identifying those at greatest risk


Understanding 30-day re-admission after hospitalisation of older patients for diabetes: identifying those at greatest risk
Gillian E Caughey, Nicole L Pratt, John D Barratt, Sepehr Shakib, Anna R Kemp-Casey and Elizabeth E Roughead
Med J Aust 2017; 206 (4): 170-175. || doi: 10.5694/mja16.00671
Objective: To identify factors that contribute to older Australians admitted to hospital with diabetes being re-hospitalised within 30 days of discharge.
Design, setting and participants: A retrospective cohort study of Department of Veterans Affairs administrative data for all patients hospitalised for diabetes and discharged alive during the period 1 January 31 December 2012.
Main outcome measures: Causes of re-hospitalisation and prevalence of clinical factors associated with re-hospitalisation within 30 days of discharge.
Methods: Multivariate logistic regression analysis (backward stepwise) was used to identify characteristics predictive of 30-day re-hospitalisation.
Results: 848 people were hospitalised for diabetes; their median age was 87 years (interquartile range, 7789 years) and 60% were men. 209 patients (24.6%) were re-hospitalised within 30 days of discharge, of whom 77.5% were re-admitted within 14 days of discharge. 51 re-hospitalisations (24%) were for diabetes-related conditions; 41% of those re-admitted within 14 days had not seen their general practitioner between discharge and re-admission. Factors predictive of re-hospitalisation included comorbid heart failure (adjusted odds ratio [aOR], 1.49; 95% confidence interval [CI], 1.032.17; P = 0.036), numbers Continue reading

No more pages to load

Popular Articles

Related Articles